Assessing the effects of probiotic supplementation in patients with metastatic melanoma on checkpoint-inhibitor therapy

被引：0
|
作者：
Vujevic, Andro [1 ]
Strikic, Dominik [1 ]
Plese, Sven [1 ]
Cegec, Ivana [1 ]
Turk, Viktorija Erdeljic [1 ]
Ausperger, Ksenija Makar [1 ]
Mikulic, Iva [1 ]
Aumiler, Matea Radacic [1 ]
Likic, Robert [1 ]
Mercep, Iveta [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0926
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [1] Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma
    Haist, Maximilian
    Stege, Henner
    Maikranz, Verena
    Halley Blanco, Maria
    Grabbe, Stephan
    Loquai, Carmen
    IMMUNO, 2022, 2 (02): : 307 - 316
  • [2] Histological features of cutaneous toxicity with checkpoint-inhibitor immunotherapy for metastatic melanoma: a retrospective case series
    Kawsar, A.
    Patel, P.
    Markiewicz, D.
    Szlosarek, P.
    Phillips, M.
    Harwood, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 117 - 117
  • [3] Treatment of Checkpoint-inhibitor Induced Colitis Leading to Worsening of Melanoma
    Pasha, Syed Bilal
    Tahan, Veysel
    Hilli, Jaffar
    Yezaz, Ghouri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1153 - S1153
  • [4] Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy
    Apostolova, Petya
    Becher, Burkhard
    Zeiser, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (03) : 294 - 296
  • [5] MANAGEMENT OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
    Voth, Elida
    Saha, Srishti
    Raffals, Laura H.
    Pardi, Darrell S.
    Khanna, Sahil
    GASTROENTEROLOGY, 2020, 158 (06) : S1165 - S1165
  • [6] Treatment with checkpoint-inhibitor immunotherapy is associated with an increased rate of hypothyreodism: A single center evaluation of Pembrolizumab treatment in fifteen patients with metastatic malignant melanoma
    Stubbe, F.
    Grosse-Thie, C.
    Schaed-Trcka, S.
    Freitag, S.
    Timmer, K.
    Lakner, J.
    Henze, L.
    Emmert, S.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 175 - 175
  • [7] The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma
    Spain, Lavinia
    Wong, Rachel
    MELANOMA MANAGEMENT, 2019, 6 (02)
  • [8] Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
    Changizzadeh, Pouyan N.
    Mukkamalla, Shiva Kumar R.
    Armenio, Vincent A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma
    van Wilpe, Sandra
    Tolmeijer, Sofie H.
    de Vries, I. Jolanda M.
    Koornstra, Rutger H. T.
    Mehra, Niven
    IMMUNO, 2021, 1 (02): : 67 - 77
  • [10] RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
    Voth, Elida
    Saha, Srishti
    Raffals, Laura
    Pardi, Darrell
    Khanna, Sahil
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S36 - S37
12345